Last reviewed · How we verify
Photocil for Vitiligo
At a glance
| Generic name | Photocil for Vitiligo |
|---|---|
| Also known as | Photocil for Vitiligo (U.S. FDA NDC: 54841-001-01) |
| Sponsor | Applied Biology, Inc. |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Photocil for Vitiligo CI brief — competitive landscape report
- Photocil for Vitiligo updates RSS · CI watch RSS
- Applied Biology, Inc. portfolio CI